Hydromer Inc (HYDI) 0.8500 $HYDI Hydromer, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hydromer Inc (HYDI) 0.8500 $HYDI

Hydromer, Inc. Announces That During the Month of July 2016, It Entered Into Two License Agreements That Each Included "Turn-Key" and Validated Medical Coating Machinery
Marketwire Canada - Thu Sep 01, 12:15PM CDT
BRANCHBURG, NJ--(Marketwired - Sep 1, 2016) - Hydromer, Inc. (OTC PINK: HYDI) announces that during the month of July it entered into two separate medical coating license agreements. Each agreement includes the sale of proprietary and in-house manufactured coating machinery.

Business Model Analysis in Antimicrobial Coatings for Medical Devices Key Players - Global Forecast to 2020
PR Newswire - Tue Jun 07, 4:37PM CDT
Antimicrobial coatings are layered onto medical devices intended to interact with biological systems. Incessant research globally for developing highly biocompatible coatings to reduce the risk of infections is a pivotal factor stimulating the growth of the global antimicrobial coatings market for medical devices. This has led to the development of metallic (including silver, copper, and zinc) and non-metallic coatings (polymers and organic coatings, among others).

The Global Antimicrobial Coatings for Medical Devices Market is Expected to Grow at a CAGR of 14.2% from 2015 to 2020 to reach USD 1.17 Billion
M2 - Tue Dec 08, 9:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/fsdsd2/antimicrobial) has announced the addition of the "Antimicrobial Coatings for Medical Devices Market - Global Forecast to 2020" report to their offering. Over the years, the medical devices manufacturers are looking for antimicrobial coatings which are biocompatible, non-toxic, and biostable for a wide range of medical devices. The demand for these antimicrobial coatings has increased significantly, owing to the increasing risk of hospital-associated infections (HAI's). There are several key factors driving growth in this market, including: - A rising awareness about hospital-acquired infections. - Favorable research and funding environment. - Technological Advancements in antimicrobial coatings. - Growing implantable devices market. - Increasing research and development activities for antimicrobial coated cardiovascular devices. - High growth in geriatric population. - And an increasing burden of cardiovascular diseases across the globe. However, the report does warn that a lack of FDA guidelines and regulations for antimicrobial coating techniques is likely to pose as a deterrent for the growth of this market. North America is expected to account for the largest share of the global antimicrobial coatings for medical devices market for medical devices, followed by Europe, Asia-Pacific, and Rest of the world (RoW) in 2015. In the coming years, the antimicrobial coatings for medical devices market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of antimicrobial coatings. Reasons to Buy the Report: The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps companies, garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Regulatory Assessment- Antimicrobial Coated Medical Devices 7 Antimicrobial Coating Market For Medical Devices, By Type Of Material 8 Antimicrobial Coatings Market For Medical Devices, By Device Type 9 Antimicrobial Coatings Market For Medical Devices, By Region 10 Competitive Landscape 11 Company Profiles - AST Products, Inc. - Basf SE - Biointeractions Ltd - Covalon Technologies Ltd. - Hydromer, Inc. - PPG Industries, Inc. - Royal DSM - Sciessent Llc - The Dow Chemical Company For more information visit http://www.researchandmarkets.com/research/fs...imicrobial
PPG: 101.26 (+0.18)

Antimicrobial Coatings for Medical Devices Market 2015 Report with Forecasts to 2020
M2 - Thu Sep 17, 3:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8s5kx6/antimicrobial) has announced the addition of the "Antimicrobial Coatings for Medical Devices Market by Type of Material (Metallic Coatings (Silver Coatings), Non-metallic Coatings (Polymeric Coatings) & Device Type (Catheters, Implantable Devices, Surgical Instruments) - Global Forecast to 2020" report to their offering. Antimicrobial coatings are used in medical devices in order to destroy or inhibit the growth of microorganisms. The market for antimicrobial coatings for medical devices covers the type of materials used for coating, and the types of devices on with the antimicrobial coatings are embedded. The medical devices include catheters, implantable devices, surgical instruments, mandrels & molds, and elastomeric seals, among others. The global antimicrobial coatings for medical devices market is expected to grow at a CAGR of 14.2% from 2015 to 2020 to reach USD 1.17 Billion by 2020 from USD 0.61 Billion in 2015. The market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is expected to grow at the fastest rate during the forecast period. The key factors that are expected to spur the growth of this market are as rising awareness about hospital-acquired infections, favorable research and funding environment, technological advancements in antimicrobial coatings, growing implantable devices market, increasing research and development activities for antimicrobial coated cardiovascular devices, high growth in geriatric population, and increasing burden of cardiovascular diseases across the globe. Moreover, factors such as growing healthcare market in emerging economies, and increasing number of free trade agreements are likely to create significant growth opportunities for players operating in the antimicrobial for medical devices coatings market in the coming years. However, lack of FDA guidelines and regulations for antimicrobial coating techniques is likely to pose as a deterrent for the growth of this market. Key Topics Covered - Introduction - Research Methodology - Executive Summary - Premium Insights - Market Overview - Regulatory Assessment- Antimicrobial Coated Medical Devices - Antimicrobial Coating Market for Medical Devices, By Type of Material - Antimicrobial Coatings Market for Medical Devices, By Device Type - Antimicrobial Coatings Market for Medical Devices, By Region - Competitive Landscape - Company Profiles - Appendix Companies Mentioned - AST Products - BASF - Biointeractions - Covalon Technologies - Hydromer - PPG Industries - Royal DSM - Sciessent - Specialty Coating Systems - The DOW Chemical Company For more information visit http://www.researchandmarkets.com/research/8s...imicrobial
PPG: 101.26 (+0.18)

Hydromer, Inc. Announces the Release of Three (3) New Medical Ultra-Hydrophilic Coatings Specifically to Stay Wet (Hydrated) Longer for Urological, Gynecological and Gastrointestinal Catheters and Devices
ACCESSWIRE - Wed Aug 19, 3:03PM CDT
BRANCHBURG, NJ / ACCESSWIRE / August 19, 2015 / Hydromer, Inc. (PINKSHEETS: HYDI) announces the release of three (3) new Medical Ultra-Hydrophilic coatings specifically to "stay wet" (hydrated) longer for use Urological, Gynecological and Gastrointestinal catheters and devices. These specialty coatings will be marketed under the "STAYWET (TM)" brand.

Medical Device Coatings Market for General Surgery, Cardiovascular, Neurology, Gynecology, Orthopedics, Dentistry and Others End-users - Global Industry Analysis 2014 - 2020
M2 - Tue Jul 14, 6:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z9wj7w/medical_device) has announced the addition of the "Medical Device Coatings Market for General Surgery, Cardiovascular, Neurology, Gynecology, Orthopedics, Dentistry and Others End-users - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering. The report analyzes and forecasts the medical device coatings market on the global and regional level. The study provides historical data of 2013 along with forecast from 2014 to 2020 based on volume (Kilo Tons) and revenue (US$ Mn). It includes drivers and restraints for the medical device coatings market along with their impact on demand during the forecast period. The report also offers an analysis of opportunities available in the medical device coatings market on the global and regional level. Drivers, restraints and opportunities mentioned in the report are justified through quantitative and qualitative data, which has been verified by primary and secondary resources. We have included a detailed value chain analysis in order to provide a comprehensive view of the medical device coatings market. Value chain analysis provides details such as integration in the market, distribution channels, applications and end-users for the market. An analysis of Porter's Five Forces model for the medical device coatings market has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein end-users in the market are benchmarked based on their market size, compounded annual growth rate (CAGR), general attractiveness and company market share. We have also incorporated company market share analysis to provide detailed analysis of the market. The study provides a decisive view of the medical device coatings market by segmenting it in terms of product segment and end-users. Product segment and end-users have been analyzed based on present and future trends, and the CAGR for the market has been estimated between 2014 and 2020. Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific and Rest of the World (RoW). Similar segmentation is also provided for major countries in the regions mentioned above. The report also includes demand for individual product segment and end-users across all the regions. The report provides detailed competitive outlook that includes profiles of key players operating in the global medical device coatings market. Key players profiled in the report include SurModics, Inc., Royal DSM N.V., Hydromer, Inc., Covalon Technologies Ltd., BioCoat, Inc., Merit Medical Systems, Inc., AST Products, Inc., PPG Industries Inc., Hydromer Inc. and Sono-Tek Corporation. Company profiles include attributes such as company overview, brand/product portfolio, financial overview, business strategy, and key/recent developments related to the market. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Medical Device Coatings - Industry Analysis Chapter 4 Medical Device Coatings Market - Product Segment Analysis Chapter 5 Medical Device Coatings Market - End-user Analysis Chapter 6 Medical device coatings Market - Regional Analysis Chapter 7 Company Profiles - AST Products, Inc. - AdvanSource Biomaterial Corporation - BioCoat, Inc. - Coatings2Go, LLC - Covalon Technologies Ltd. - Harland Medical Systems, Inc. - Hemoteq AG - Hydromer, Inc. - Merit Medical Systems, Inc. - PPG Industries, Inc. - Precision Coating Company, Inc. - Royal DSM N.V. - Sono-Tek Corporation - Specialty Coating Systems, Inc. - SurModics, Inc. For more information visit http://www.researchandmarkets.com/research/z9...cal_device
SRDX: 28.52 (-0.05), PPG: 101.26 (+0.18), MMSI: 24.23 (-0.18)

Medical Coatings (Hydrophilic and Hydrophobic coatings) Market - Regional Trends & Forecast to 2019
M2 - Mon Feb 16, 6:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/nhzhtk/medical_coatings) has announced the addition of the "Medical Coatings Market by Type, Application and Geography - Regional Trends & Forecast to 2019" report to their offering. The medical coatings market was estimated around $9.1 billion in 2013, with the high share of around 70% held by North America and Europe together. The global medical coatings market by value is projected to grow at a CAGR of 6.5% from 2014 to 2019. The high growth is forecasted to be in the Asia-Pacific due to rise of medical device manufacturing in the region. Europe is estimated to have the second highest growth around 6.37% from 2014 to 2019. Advancements in medical device designing have led to improvement of existing medical devices as well as introduction of new technologies. These devices are made of metals such as stainless steel, aluminum or ceramic such as bioglass or alumina. Not all these materials are compatible when in contact with tissues and body fluids and can cause complications, for instance, infection and blood clots. Coatings help to remove these difficulties. Some coatings help to make the device biocompatible while others help to prevent microbial infections. It may also be hydrophilic or hydrophobic according to the requirement. Coatings also help to reduce static and kinetic friction between two different surfaces. Based on properties, medical coatings can be broadly classified into hydrophilic and hydrophobic coatings. However, there are other types of coatings such as antimicrobial, protective, optical, lubricious, pharmacological and so. The most commonly used chemistries in coatings are parylene, silicones, and fluoropolymers. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Medical Coatings Market, By Type 8 Medical Coatings Market, By Application 9 Regional Analysis 10 Competitive Landscape 11 Company Profiles - AST Products Inc. - Abbott Laboratories - Biocoat Inc. - Covalon Technologies Ltd. - Harland Medical Systems Inc. - Hydromer Inc. - Precision Coatings Co. Inc. - Royal DSM - Specialty Coating Systems Inc. - Surmodics Inc. For more information visit http://www.researchandmarkets.com/research/nh...l_coatings
ABT: 41.58 (-0.10)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

You Call The Play Inc. (YCTP) Leads with Integrity in Betting

Updated Category News Views 154

Understanding You Call The Play Inc. (YCTP)'s Initiative In an important move for the sports betting landscape, You Call The Play Inc. (YCTP) has recently unveiled a national licensing plan and a groundbreaking measure called the Safe Bet Overlay™. This initiative is designed to foster trust and transparency within an industry that continues to grow rapidly across the...

Continue Reading
Cash for Houses Pro Earns Stellar Reputation with 5-Star Reviews

Updated Category News Views 167

Cash for Houses Pro Achieves 5-Star Reviews Cash for Houses Pro is celebrating their recent success in receiving numerous 5-star reviews on Google for their service known as 'Sell Your House Fast In Tampa FL For Cash'. This recognition reflects the team's dedication to providing homeowners with a seamless and stress-free home selling experience. About Cash for Houses Pro...

Continue Reading
Pfizer's Potential Transformation Following Starboard Investment

Updated Category News Views 77

Pfizer's Revised Price Target and Market Standing Recently, CFRA, a prominent financial research firm, elevated its price target for Pfizer Inc. (NYSE:PFE) from $30.00 to $31.00 per share. This adjustment comes while maintaining a 'Hold' rating on the stock, suggesting a careful observation of its market performance. The current price target reflects a valuation based on...

Continue Reading
Equinox Gold's Impressive Q2 Results Spark Stock Surge Today

Updated Category News Views 103

Equinox Gold Delivers Strong Quarterly Performance Equinox Gold Corp. EQX has seen its shares rise significantly following the release of its second-quarter financial results, which exceeded market expectations. Investors reacted favorably, driving the stock up on Thursday. Financial Highlights from the Quarter In the latest quarterly report, Equinox Gold announced...

Continue Reading
Investor Insights on Alexandria Real Estate Equities' Legal Challenges

Updated Category News Views 219

Understanding the Alexandria Real Estate Equities, Inc. Lawsuit Investors have an important opportunity arising from a lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE). A national shareholder rights litigation firm has initiated a class action alleging the Company has violated various securities laws. This situation has caught the attention of many...

Continue Reading